cabiralzumab

cabiralzumab · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for cabiralzumab, covering 2020-12-21 to 2020-12-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread [Phase 1]